제약 미생물학 품질관리 검사 시장 규모, 점유율과 동향 분석 보고서 : 제품 유형별, 검사 유형별, 기술별, 용도별, 지역별, 부문 예측(2026-2033년)
Pharmaceutical Microbiology QC Testing Market Size, Share & Trends Analysis Report By Product, By Test Type, By Technique, By Application, By Region, And Segment Forecasts, 2026 - 2033
상품코드:1941903
리서치사:Grand View Research
발행일:2026년 01월
페이지 정보:영문 150 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
제약 미생물학 품질관리 검사 시장 요약
세계의 제약 미생물학 품질관리 검사 시장 규모는 2025년에 40억 3,000만 달러로 추정되며, 2033년까지 106억 달러에 달할 것으로 예측됩니다.
2026-2033년 연평균 복합 성장률(CAGR) 12.98%를 나타낼 것으로 예측됩니다. 기술 발전, 규제 압력, 환자 안전과 제품 품질에 대한 관심 증가로 인해 이 산업은 괄목할 만한 성장을 이룩했습니다.
The global pharmaceutical microbiology QC testing market size was estimated at USD 4.03 billion in 2025 and is projected to reach USD 10.60 billion by 2033, growing at a CAGR of 12.98% from 2026 to 2033. The industry is experiencing significant growth, driven by a combination of technological advancements, regulatory pressures, and an increasing emphasis on patient safety and product quality.
Global Pharmaceutical Microbiology QC Testing Market Report Segmentation
This report forecasts revenue growth at the global, regional and country levels and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pharmaceutical microbiology QC testing market report on the basis of product, test type, technique, application, and region.
Product Outlook (Revenue, USD Million, 2021 - 2033)
Instruments
Reagents & Kits
Accessories
Software
Test Type Outlook (Revenue, USD Million, 2021-2033)
Traditional/Conventional Testing
Rapid Testing
Technique Outlook (Revenue, USD Million, 2021-2033)
Growth-based Testing
Nucleic Acid-based Testing
Cellular Component-based Testing
Viability-based Testing
Other Techniques
Application Outlook (Revenue, USD Million, 2021-2033)
Bioburden testing
Sterility testing
Environmental monitoring
Endotoxin testing
Pyrogen testing
Mycoplasma testing
Microbial identification
Other applications
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Product Segment
1.2.2. Test Type Segment
1.2.3. Technique Segment
1.2.4. Application Segment
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.9.1. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Increasing focus on quality control and rising microbiology testing needs
3.3.2. Technological advancements in rapid testing
3.4. Market Restraint Analysis
3.4.1. Expensive equipment and technology hinder market adoption
3.4.2. Complex regulations slow down the approval and implementation process
3.5. Business Environment Analysis
3.5.1. PESTEL Analysis
3.5.2. Porter's Five Forces Analysis
Chapter 4. Product Business Analysis
4.1. Product Segment Dashboard
4.2. Global Pharmaceutical Microbiology QC Testing Market: Product Movement Analysis
4.3. Global Pharmaceutical Microbiology QC Testing Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
